Your browser doesn't support javascript.
loading
Nirmatrelvir-ritonavir therapy and COVID-19 vaccination improve clinical outcomes of SARS-CoV-2 Omicron variant infection.
Qi, Tangkai; Jin, Yinpeng; Wang, He; Liao, Yixin; Liu, Tiefu; Mao, Enqiang; Li, Feng; Li, Yinchuan; Fan, Xiaohong; Ling, Yun.
Afiliación
  • Qi T; Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Jin Y; Liver Disease Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Wang H; Surgical Care Unit, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Liao Y; Scientific Research Center, Shanghai Public Health Clinical Center, Shanghai, China.
  • Liu T; Scientific Research Center, Shanghai Public Health Clinical Center, Shanghai, China.
  • Mao E; Department of Emergency of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li F; Department of Respiratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Li Y; Intensive Care Unit of Shanghai Tenth People's Hospital Affiliated to Tongji University, Shanghai, China.
  • Fan X; Department of Respiratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Ling Y; Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
J Med Virol ; 95(2): e28497, 2023 02.
Article en En | MEDLINE | ID: mdl-36651302

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China